Jazz Pharmaceuticals PLC at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing the 44th Annual Healthcare Conference today with Jazz. First, you're going to hear a presentation from the company's CEO, and then we're going to go into some Q&A. (Event Instructions)
So with that, let me pass it over to Jazz's CEO, Renee Gala.
Great. Good morning, everyone, and thank you, Jess, and thank you, JPMorgan, for having us. I have been attending this conference for a number of years, but this is my first as Jazz's CEO. It's such an honor to be in this role and to build upon Bruce Cozadd's amazing legacy.
I'm also excited to be in a position to work with our Board, our management team, and our employees to boldly move Jazz forward to realize the potential that I see for us to bring life-changing medicines to patients, to drive into the most incredible work experience that our employees are able to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
